Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Medicine|August 19, 2022
Perceptions and attitudes toward participation in clinical research in the Eastern Mediterranean Region: A systematic reviewMohamed Aabdien, Ibtihal Abdallah, Mohamed Iheb Bougmiza, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 24, 2016
Blood glucose control for patients with acute coronary syndromes in QatarKyle John Wilby, Eman Elmekaty, Ibtihal Abdallah, et al.Cureus|April 6, 2022
Treatment Failure of Cerebral Venous Thrombosis With Rivaroxaban: A Case Report and Narrative ReviewMustafa Mohamed, Muzamil Musa, Abdalla Fadul, et al.European Journal of Clinical Pharmacology|October 10, 2023
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world dataMajdoleen Alalawneh, Ousama Rachid, Ibtihal Abdallah, et al.Journal of Thrombosis and Thrombolysis|June 20, 2020
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysisMohamed Nabil Elshafei, Mouhand F H Mohamed, Ahmed El-Bardissy, et al.Clinical and Translational Science|June 7, 2024
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK)Majdoleen Alalawneh, Ahmed Awaisu, Ibtihal Abdallah, et al.The Annals of Pharmacotherapy|February 18, 2022
Thrombocytopenia Associated With Teicoplanin Use: A Retrospective Observational StudyReem Elajez, Ibtihal Abdallah, Dana Bakdach, et al.Journal of Thrombosis and Thrombolysis|October 5, 2020
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemicIbtihal Abdallah, Asma Eltahir, Liam Fernyhough, et al.Pageof 1